Basic HTML-Version
Erfolgreiche Therapie bei drohendem Leber-
versagen nach Reaktivierung einer Hepatitis B
G. Lock, F. Helmich, M. Bertram
aus BDI aktuell 8-9/2012
Literatur
1 Brost S, Schnitzler P, Stremmel W et al. Entecavir as treatment for reactivation of hepatitis B in
immunosuppressed patients. World J Gastroenterol 2010; 16: 5447-5451
2 Coppola N, Tonziello G, Pisaturo M et al. Reactivation of overt and occult hepatitis B infection in various
immunosuppressive settings. J Med Virol 2011; 83: 1909-1916
3 Cornberg M, Protzer U, Petersen J et al. Aktualisierung der S3-Leitlinie zur Prophylaxe, Diagnostik und Therapie
der Hepatitis-B-Virusinfektion. Z Gastroenterol 2011; 49: 871-930
4 Francisci D, Falcinelli F, Schiaroli E et al. Management of hepatitis B virus reactivation in patients with
hematological malignancies treated with chemotherapy. Infection 2010; 38: 58-61
5 Katz LH, Fraser A, Gafter-Gvili A et al. Lamivudine prevents reactivation of hepatitis B and reduces mortality in
immunosuppressed patients: systematic review and meta-analysis. J Viral Hepat 2008; 15: 89-102
6 Li HR, Huang JJ, Guo HQ et al. Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in
lymphoma patients during chemotherapy. J Viral Hepat 2011; 18: 877-883
7 Manzano-Alonso ML, Castellano-Tortajada G. Reactivation of hepatitis B virus infection after cytotoxic
chemotherapy or immunosuppressive therapy. World J Gastroenterol 2011; 17: 1531-1537
8 Martyak LA, Taqavi E, Saab S. Lamivudine prophylaxis is effective in reducing hepatitis B reactivation and
reactivation-related mortality in chemotherapy patients: a meta-analysis. Liver Int 2008; 28: 28-38
9 Montineri A, Nigro L, La Rosa R et al. Treatment induced seroconversion of HBs AG following HBV reactivation in
the immunosuppressed haematology and oncology patient. J Clin Virol 2011; 52: 284-287
10 Rago A, Lichtner M, Mecarocci S et al. Antiviral treatment including entecavir plus tenofovir disoproxil fumarate
for HBV reactivation following a rituximab-based regimen. Antivir Ther 2010; 15: 929-932
11 Sanchez MJ, Buti M, Homs M et al. Successful use of entecavir for a severe case of reactivation of hepatitis B
virus following polychemotherapy containing rituximab. J Hepatol 2009; 51: 1091-1096
12 Stange MA, Tutarel O et al. Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation.
Z Gastroenterol 2010; 48: 258-263
13 Tillmann HL, Zachou K, Dalekos GN. Management of severe acute to fulminant hepatitis B: to treat or not to
treat and when to treat?. Liver Int 2011; 32: 544-553
14 Wursthorn K, Wedemeyer H, Manns MP. Managing HBV in patients with impaired immunity. Gut 2010; 59:
1430-1445